Superdisintegrants Market by Product Modified Starch Modified Cellulose Crospovidone Ion Exchange Resin Formulation Tablet Capsules Therapeutic Area Gastrointestinal Cardiovascular Neurology Oncology Hematology Global Forecast to 2023 Report U

Superdisintegrants Market by Product Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin, Formulation Tablet, Capsules, Therapeutic Area Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology Global Forecast to 2023 [Report U

19:46 EDT 23 Oct 2018 | BioPortfolio Reports

The global superdisintegrants market is projected to grow at a CAGR of 7.9%.

The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.


The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period.

By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, crosslinked polyvinylpyrrolidone crospovidone, modified cellulose, ion exchange resins, and calcium silicates. The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.


Tablet formulation segment is expected to witness the highest growth during the forecast period.

By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets ODT and fastdisintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.


APAC superdisintegrants market is projected to witness the highest growth during the forecast period.

Europe held the largest share of the global superdisintegrants market in 2017. On the other hand, the APAC superdisintegrants market is expected to witness the highest CAGR during the forecast period, owing to the significant growth in pharmaceutical manufacturing in the past few years, lowcost manufacturing advantage, increasing per capita income, low regulatory stringency, and growing interest of key players in APAC countries.


Break of primary participants was as mentioned below:

By Company Type: Tier 148%, Tier 234% and Tier 318%

By Designation: Clevel42%, Director Level40%, Others18%

By Region: North America38%, Europe32%, Asia Pacific21%, Latin America6%, Middle East Africa3%


The prominent players in the global superdisintegrants market are Ashland Inc. US, BASF SE Germany, DowDuPont US, JRS Pharma Germany, DFE Pharma Germany, Roquette France, Asahi Kasei Corporation Japan, Merck KGaA Germany, Corel Pharma Chem India, and Avantor Performance Materials, LLC US.


Research Coverage:

The report analyzes the various superdisintegrants products and their adoption pattern. It aims at estimating the market size and future growth potential of the global superdisintegrants market for different segments by type, formulation, therapeutic area, and region. The report also includes an indepth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening the market.


This report provides insights on the following pointers:

Market Penetration: Comprehensive information on product portfolios offered by the top players in the global superdisintegrants market

Product Development/Innovation: Detailed insights on upcoming trends, RD activities, and product launches in the global superdisintegrants market

Market Development: Comprehensive information on the lucrative and emerging market

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global superdisintegrants market

Competitive Assessment: Indepth assessment of market shares, growth strategies, and products of leading players in the global superdisintegrants market

More From BioPortfolio on "Superdisintegrants Market by Product Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin, Formulation Tablet, Capsules, Therapeutic Area Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology Global Forecast to 2023 [Report U"